Cargando…

Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse

INTRODUCTION AND HYPOTHESIS: There is growing interest in and performance of uterine-preserving prolapse repairs. We hypothesized that there would be no difference in pelvic organ prolapse (POP) recurrence 2 years following transvaginal uterosacral ligament hysteropexy (USLH) and sacrospinous ligame...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickman, Lisa C., Tran, Misha C., Paraiso, Marie Fidela R., Walters, Mark D., Ferrando, Cecile A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479721/
https://www.ncbi.nlm.nih.gov/pubmed/34586437
http://dx.doi.org/10.1007/s00192-021-04987-5
_version_ 1784576319464407040
author Hickman, Lisa C.
Tran, Misha C.
Paraiso, Marie Fidela R.
Walters, Mark D.
Ferrando, Cecile A.
author_facet Hickman, Lisa C.
Tran, Misha C.
Paraiso, Marie Fidela R.
Walters, Mark D.
Ferrando, Cecile A.
author_sort Hickman, Lisa C.
collection PubMed
description INTRODUCTION AND HYPOTHESIS: There is growing interest in and performance of uterine-preserving prolapse repairs. We hypothesized that there would be no difference in pelvic organ prolapse (POP) recurrence 2 years following transvaginal uterosacral ligament hysteropexy (USLH) and sacrospinous ligament hysteropexy (SSLH). METHODS: This is a retrospective cohort study with a cross-sectional survey of women who underwent transvaginal uterine-preserving POP surgery from May 2016 to December 2017. Patients were included if they underwent either USLH or SSLH. POP recurrence was defined as a composite of subjective symptoms and/or retreatment. A cross-sectional survey was used to assess pelvic floor symptoms and patient satisfaction. RESULTS: A total of 47 women met the criteria. Mean age was 52.8 ± 12.5 years, and all had a preoperative POP-Q stage of 2 (55.3%) or 3 (44.7%). Thirty (63.8%) underwent SSLH and 17 (36.2%) underwent USLH. There were no differences in patient characteristics or perioperative data. There was no difference in composite recurrence (26.7% [8] vs 23.5% [4]) and retreatment (6.7% [2] vs 0%) retrospectively between SSLH and USLH groups at 22.6 months. Survey response rate was 80.9% (38) with a response time of 30.7 (28.0–36.6) months. The majority of patients (84.2%) reported POP symptom improvement, and both groups reported great satisfaction (89.5%). In respondents, 13.2% (5) reported subjective recurrence and 5.3% (2) underwent retreatment, with no differences between hysteropexy types. There were no differences in other pelvic floor symptoms. CONCLUSIONS: Although 1 in 4 women experienced subjective POP recurrence after transvaginal uterine-preserving prolapse repair and <5% underwent retreatment at 2 years, our results must be interpreted with caution given our small sample size. No differences in outcomes were identified between hysteropexy types; however, additional studies should be performed to confirm these findings. Both hysteropexy approaches were associated with great patient satisfaction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00192-021-04987-5
format Online
Article
Text
id pubmed-8479721
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84797212021-09-30 Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse Hickman, Lisa C. Tran, Misha C. Paraiso, Marie Fidela R. Walters, Mark D. Ferrando, Cecile A. Int Urogynecol J Original Article INTRODUCTION AND HYPOTHESIS: There is growing interest in and performance of uterine-preserving prolapse repairs. We hypothesized that there would be no difference in pelvic organ prolapse (POP) recurrence 2 years following transvaginal uterosacral ligament hysteropexy (USLH) and sacrospinous ligament hysteropexy (SSLH). METHODS: This is a retrospective cohort study with a cross-sectional survey of women who underwent transvaginal uterine-preserving POP surgery from May 2016 to December 2017. Patients were included if they underwent either USLH or SSLH. POP recurrence was defined as a composite of subjective symptoms and/or retreatment. A cross-sectional survey was used to assess pelvic floor symptoms and patient satisfaction. RESULTS: A total of 47 women met the criteria. Mean age was 52.8 ± 12.5 years, and all had a preoperative POP-Q stage of 2 (55.3%) or 3 (44.7%). Thirty (63.8%) underwent SSLH and 17 (36.2%) underwent USLH. There were no differences in patient characteristics or perioperative data. There was no difference in composite recurrence (26.7% [8] vs 23.5% [4]) and retreatment (6.7% [2] vs 0%) retrospectively between SSLH and USLH groups at 22.6 months. Survey response rate was 80.9% (38) with a response time of 30.7 (28.0–36.6) months. The majority of patients (84.2%) reported POP symptom improvement, and both groups reported great satisfaction (89.5%). In respondents, 13.2% (5) reported subjective recurrence and 5.3% (2) underwent retreatment, with no differences between hysteropexy types. There were no differences in other pelvic floor symptoms. CONCLUSIONS: Although 1 in 4 women experienced subjective POP recurrence after transvaginal uterine-preserving prolapse repair and <5% underwent retreatment at 2 years, our results must be interpreted with caution given our small sample size. No differences in outcomes were identified between hysteropexy types; however, additional studies should be performed to confirm these findings. Both hysteropexy approaches were associated with great patient satisfaction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00192-021-04987-5 Springer International Publishing 2021-09-29 2022 /pmc/articles/PMC8479721/ /pubmed/34586437 http://dx.doi.org/10.1007/s00192-021-04987-5 Text en © The International Urogynecological Association 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Hickman, Lisa C.
Tran, Misha C.
Paraiso, Marie Fidela R.
Walters, Mark D.
Ferrando, Cecile A.
Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse
title Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse
title_full Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse
title_fullStr Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse
title_full_unstemmed Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse
title_short Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse
title_sort intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479721/
https://www.ncbi.nlm.nih.gov/pubmed/34586437
http://dx.doi.org/10.1007/s00192-021-04987-5
work_keys_str_mv AT hickmanlisac intermediatetermoutcomesaftertransvaginaluterinepreservingsurgeryinwomenwithuterovaginalprolapse
AT tranmishac intermediatetermoutcomesaftertransvaginaluterinepreservingsurgeryinwomenwithuterovaginalprolapse
AT paraisomariefidelar intermediatetermoutcomesaftertransvaginaluterinepreservingsurgeryinwomenwithuterovaginalprolapse
AT waltersmarkd intermediatetermoutcomesaftertransvaginaluterinepreservingsurgeryinwomenwithuterovaginalprolapse
AT ferrandocecilea intermediatetermoutcomesaftertransvaginaluterinepreservingsurgeryinwomenwithuterovaginalprolapse